US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 8.280
  • -0.380-4.39%
Close Mar 28 16:00 ET
  • 8.220
  • -0.060-0.72%
Post 16:58 ET
509.06MMarket Cap-1.26P/E (TTM)

About Sage Therapeutics Company

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees353
Fiscal Year Ends12-31
Address55 Cambridge Parkway
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Barry E. Greene
  • Director, President and Chief Executive Officer
  • 6.24M
  • Christopher Benecchi
  • Chief Operating Officer, Treasurer, Principal Financial and Accounting Officer
  • 2.28M
  • Dr. Mike Quirk, PhD
  • Chief Scientific Officer
  • --
  • Dr. Steven M. Paul, M.D.
  • Independent Director
  • 420.05K
  • Jessica J. Federer
  • Independent Director
  • 962.23K
  • Elizabeth Barrett
  • Independent Director
  • 425.05K
  • Michael F. Cola
  • Independent Director
  • 440.05K
  • James M. Frates
  • Independent Director
  • 435.05K
  • Geno J. Germano
  • Independent Director
  • 417.55K
  • Dr. George S. Golumbeski, PhD
  • Independent Director
  • 412.55K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shenzhen Kaifa Technology
920029
+150.36%
Shanghai Yongli Belting
300230
+20.04%
Guomai Culture & Media
301052
+20.00%
4
WuHan Hvsen Biotechnology
300871
+19.05%
5
CHANGFU CO.,LTD
871396
+18.10%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call